All Stories

  1. Distinct dendritic cell cytoskeletal programs dictate synapse architecture and CD8+ T cell fate
  2. Intact lymph node homing and CD8+ T-cell priming abilities of Sprouty2-deficient dendritic cells
  3. NLRP3 activators disrupt the endocytic AP2 complex and plasma membrane signaling
  4. uPA-mediated remodeling of CCL21 gradients regulates lymphatic migration of dendritic cells
  5. NUPA10hd-immortalized and genetically engineered progenitors allow studying dendritic cell immune functions
  6. Dual Role of Plasmacytoid Dendritic Cells in Humoral and CD8⁺ T Cell Memory Post COVID-19 mRNA Vaccination
  7. Inclusion of ACKR5 in the systematic nomenclature of atypical chemokine receptors
  8. Identification of critical residues at the C-terminal tip of ACKR4 regulating chemokine internalization and βarrestin involvement
  9. International Union of Basic and Clinical Pharmacology. CXVIII. Update on the Nomenclature for Atypical Chemokine Receptors including ACKR5
  10. ACKR5/GPR182 is a scavenger receptor for the atypical chemokine CXCL17, GPR15L and various endogenous peptides
  11. Exocrine gland–resident memory CD8 + T cells use mechanosensing for tissue surveillance
  12. Naive T lymphocytes chemotax long distance to CCL21 but not to a source of bioactive S1P
  13. GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity
  14. Reassessing the adrenomedullin scavenging function of ACKR3 in lymphatic endothelial cells
  15. Naïve T lymphocytes chemotax to CCL21 but not to S1P-rich serum
  16. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling
  17. Rapid increase in transferrin receptor recycling promotes adhesion during T cell activation
  18. Distinct Fates of Chemokine and Surrogate Molecule Gradients: Consequences for CCR7-Guided Dendritic Cell Migration
  19. Shifting CCR7 towards Its Monomeric Form Augments CCL19 Binding and Uptake
  20. Delineating the interactions between the cannabinoid CB 2 receptor and its regulatory effectors; β‐arrestins and GPCR kinases
  21. Mechanosensitive ACKR4 scavenges CCR7 chemokines to facilitate T cell de-adhesion and passive transport by flow in inflamed afferent lymphatics
  22. Elimination of negative feedback in TLR signalling allows rapid and hypersensitive detection of microbial contaminants
  23. CAL-1 as Cellular Model System to Study CCR7-Guided Human Dendritic Cell Migration
  24. The dimeric form of CXCL12 binds to atypical chemokine receptor 1
  25. CCR7 signalosomes are preassembled on tips of lymphocyte microvilli in proximity to LFA-1
  26. A Versatile Toolkit for Semi-Automated Production of Fluorescent Chemokines to Study CCR7 Expression and Functions
  27. Medullary stromal cells synergize their production and capture of CCL21 for T-cell emigration from neonatal mouse thymus
  28. Keratinocytes control skin immune homeostasis through de novo–synthesized glucocorticoids
  29. Functional Heterogeneities in Biomembranes
  30. CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
  31. β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4
  32. B cell zone reticular cell microenvironments shape CXCL13 gradient formation
  33. CCR 5 deficiency/ CCR 5Δ32: resistant to HIV infection at the cost of curtailed CD 4 + T cell memory responses
  34. CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
  35. FAT10 localizes in dendritic cell aggresome-like induced structures and contributes to their disassembly
  36. CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4
  37. Membrane Compartmentalization and Scaffold Proteins in Leukocyte Migration
  38. ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins
  39. Atypical Functions of Leukocyte Chemoattractant Receptors
  40. ImmunoPhysics and ImmunoEngineering
  41. Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation
  42. In Vivo Function of the Lipid Raft Protein Flotillin-1 during CD8+ T Cell–Mediated Host Surveillance
  43. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
  44. Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7
  45. Interleukin-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation
  46. CCR7 Is Recruited to the Immunological Synapse, Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP70
  47. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions
  48. Role of Mechanotransduction and Tension in T Cell Function
  49. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins
  50. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells
  51. Beyond migration-Chemokines in lymphocyte priming, differentiation, and modulating effector functions
  52. A unique signal sequence of the chemokine receptor CCR7 promotes package into COPII vesicles for efficient receptor trafficking
  53. Membrane lipid environment: Potential modulation of chemokine receptor function
  54. New insights in chemokine signaling
  55. A structure–activity relationship linking non-planar PCBs to functional deficits of neural crest cells: new roles for connexins
  56. Chemokine activity modulation
  57. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
  58. Chemokines: Chemistry, Biochemistry and Biological Function
  59. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors
  60. Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses
  61. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes
  62. Inflammation-Induced CCR7 Oligomers Form Scaffolds to Integrate Distinct Signaling Pathways for Efficient Cell Migration
  63. The STEAP1262-270peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic mice-A new approach to immunotherapy against prostate carcinoma
  64. Loss of Gadkin Affects Dendritic Cell Migration In Vitro
  65. In vivo TCR Signaling in CD4+ T Cells Imprints a Cell-Intrinsic, Transient Low-Motility Pattern Independent of Chemokine Receptor Expression Levels, or Microtubular Network, Integrin, and Protein Kinase C Activity
  66. Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity
  67. Analysis of CCR7 mediated T cell transfectant migration using a microfluidic gradient generator
  68. On the move: endocytic trafficking in cell migration
  69. Regulation of Sec16 levels and dynamics links proliferation and secretion
  70. CCR7: Roles in cancer cell dissemination, migration and metastasis formation
  71. Interstitial Dendritic Cell Guidance by Haptotactic Chemokine Gradients
  72. Converse regulation of CCR7-driven human dendritic cell migration by prostaglandin E2and liver X receptor activation
  73. Ubiquitylation of the chemokine receptor CCR7 enables efficient receptor recycling and cell migration
  74. Surface Engineering of Biomembranes with GPI-Anchored Proteins and its Applications
  75. Distinct modulation of chemokine expression patterns in human monocyte-derived dendritic cells by prostaglandin E2
  76. Cross-Talk Between TCR and CCR7 Signaling Sets a Temporal Threshold for Enhanced T Lymphocyte Migration
  77. Definition of Key Variables for the Induction of Optimal NY-ESO-1-Specific T Cells in HLA Transgene Mice
  78. Immobilized Chemokine Fields and Soluble Chemokine Gradients Cooperatively Shape Migration Patterns of Dendritic Cells
  79. Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances
  80. Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process
  81. Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
  82. Prostaglandin E2 enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells
  83. Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis
  84. Reduced Expression of Cyclooxygenase-2 in Primary Breast Cancer
  85. Increased Mobility of Major Histocompatibility Complex I-Peptide Complexes Decreases the Sensitivity of Antigen Recognition
  86. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon
  87. V domain of RAGE interacts with AGEs on prostate carcinoma cells
  88. A novel cytosolic class I antigen-processing pathway for endoplasmic-reticulum-targeted proteins
  89. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO
  90. Opposite Fate of Endocytosed CCR7 and Its Ligands: Recycling versus Degradation
  91. Posttranscriptional regulation of Fas (CD95) ligand killing activity by lipid rafts
  92. Preformed reggie/flotillin caps: stable priming platforms for macrodomain assembly in T cells
  93. Prostaglandin E2 Is Generally Required for Human Dendritic Cell Migration and Exerts Its Effect via EP2 and EP4 Receptors
  94. Differential insertion of GPI-anchored GFPs into lipid rafts of live cells
  95. PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction
  96. Theα vβ 3 integrin as a tumor homing ligand for lymphocytes
  97. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
  98. Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation
  99. The β1and β3Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation
  100. Soluble Major Histocompatibility Complex-Peptide Octamers with Impaired CD8 Binding Selectively Induce Fas-dependent Apoptosis
  101. CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation
  102. Association of the Epstein-Barr virus latent membrane protein 1 with lipid rafts is mediated through its N-terminal region
  103. Selective inhibition of CTL activation by a dipalmitoyl-phospholipid that prevents the recruitment of signaling molecules to lipid rafts
  104. CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts
  105. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes
  106. Activation-dependent modulation of B lymphocyte migration to chemokines
  107. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7
  108. B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5
  109. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function
  110. Identification of CCR8, the Receptor for the Human CC Chemokine I-309
  111. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
  112. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1